Taysha Gene Therapies shares owned by Citadel Advisors
Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Taysha Gene Therapies
Tip: Access up to 7 years of quarterly data
All positions including Taysha Gene Therapies held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Taysha Gene Therapies by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $5.8M | 2.9M | 2.01 |
| 2024-06-30 | $184k | 82k | 2.24 |
| 2024-03-31 | $211k | 74k | 2.87 |
| 2023-12-31 | $4.1M | 2.3M | 1.77 |
| 2023-09-30 | $197k | 62k | 3.16 |
| 2023-06-30 | $9.2k | 14k | 0.66 |
| 2023-03-31 | $11k | 14k | 0.80 |
| 2022-12-31 | $573k | 254k | 2.26 |
| 2022-06-30 | $496k | 134k | 3.72 |
| 2022-03-31 | $1.5M | 225k | 6.52 |
| 2021-12-31 | $423k | 36k | 11.64 |
| 2020-12-31 | $950k | 36k | 26.56 |
| 2020-09-30 | $5.5M | 245k | 22.40 |